About Hainan Shuangcheng Pharmaceuticals Company

The company is a high-tech enterprise founded in 2000, characterized by chemically synthesizing polypeptide drugs. It specializes in the production, sales and development of chemically synthesized polypeptide drugs. The company has formed a complete mature technical process system in the synthesis, purification, analysis, quality assurance, activity determination, and formulation process of chemically synthesized polypeptide drugs. The company was listed on the small to medium edition of the Shenzhen Stock Exchange on August 8, 2012. The company's main business covers research, development, production and sales of injections, capsules, tablets, granules and APIs; production and sales of chemical products (except franchised) and general machinery and equipment. The company's main products are Ketai (product name) injectable thymus, injectable bivalirudine, injectable levocarnitine, injectable clindamycin hydrochloride, injectable famotidine, injectable somatostatin, injectable ligustrazine phosphate, etc. Corporate honors: National Torch Program Project Certificate; High-tech Enterprise in Hainan Province; 2002 Honest Tax Paying Enterprise; Famous Trademark of Hainan Province, etc.